Published in TB and Outbreaks Week, June 28th, 2005
EBV "has the potential to undergo latent and lytic pathways during infection," virologists in Taiwan explained. "However, expression of many of the viral genes during the lytic-latent transition remains unclear."
In their study, Y.R. Pan and coauthors at National Tsing Hua University "investigated the effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) and hydroxyurea (HU), two...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.